The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Quality of life and cognitive dysfunction in breast cancer survivors on a feasibility study of donepezil versus placebo.
Julia Lawrence
No relevant relationships to disclose
Leah Griffin
No relevant relationships to disclose
Steve Rapp
No relevant relationships to disclose
Michael J. Messino
No relevant relationships to disclose
Ernie P. Balcueva
No relevant relationships to disclose
Amarinthia E. Curtis
No relevant relationships to disclose
David L. Groteluschen
No relevant relationships to disclose
Thomas A. Samuel
No relevant relationships to disclose
Glenn Lesser
No relevant relationships to disclose
Doug Case
No relevant relationships to disclose
Edward G. Shaw
No relevant relationships to disclose